Research Grade Tibulizumab
Overview
Catalog No.
HS856106
Host species
Humanized
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Purity
>95% as determined by SDS-PAGE.
Clonality
Monoclonal
Isotype
IgG4-kappa-[scFv]2
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Target
CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, BAFF, ZTNF4, BLYS, Tumor necrosis factor ligand superfamily member 13B, Dendritic cell-derived TNF-like molecule, TALL-1, TNF- and APOL-related leukocyte expressed ligand 1, BLyS, B lymphocyte stimulator, TNFSF13B, CD257, TNFSF20, TALL1, B-cell-activating factor
Purification
Protein A/G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
Mammalian Cells
Accession
Q16552 & Q9Y275
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative name
Bispecific, LY 3090106, LY-3090106, LY3090106, 1849636-24-3
Species
Human
Note
For research use only. Not suitable for clinical or therapeutic use.
Images
SDS-PAGE
SDS-PAGE for Research Grade Tibulizumab.
Bioactivity
Detects Human IL17A in direct ELISAs.